Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study
The recent outbreak of novel Coronavirus disease 2019 (COVID-19) has become a pandemic and is threatening global health.1 The highest number of COVID-19 confirmed cases were reported in the United States, with 1.47 million confirmed cases and 89,272 deaths as of 05/19/2020.2 Inflammatory bowel disea...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12085
- Acceso en línea:
- https://doi.org/10.1053/j.gastro.2020.05.065
http://hdl.handle.net/20.500.12010/12085
- Palabra clave:
- Anti-TNF
Thiopurines medications
COVID-19
Patients with inflammatory bowel disease
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido